ストックスクリーナーアプリを入手
2.11
4.09%
-0.09
アフターアワーズ：
2.10
-0.010
-0.47%
前日終値:
$2.20
開ける：
$2.1
24時間の取引高:
13,545
Relative Volume:
0.62
時価総額：
$6.79M
収益：
-
当期純損益:
$-7.72M
株価収益率:
-0.8373
EPS:
-2.52
ネットキャッシュフロー:
$-6.25M
1週間 パフォーマンス:
-4.09%
1か月 パフォーマンス:
-44.81%
6か月 パフォーマンス:
-53.63%
1年 パフォーマンス:
-24.64%
1日の値動き範囲:
$2.05
$2.1611
1週間の範囲:
$2.05
$2.32
52週間の値動き範囲:
$2.05
$6.46
Edesa Biotech Inc Stock (EDSA) Company Profile
EDSA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
| EDSA | 2.11 | 6.79M | 0 | -7.72M | -6.25M | -2.52 |
| VRTX | 450.37 | 115.10B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 744.50 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 596.74 | 35.07B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 246.80 | 32.20B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 108.23 | 25.09B | 3.30B | -501.07M | 1.03B | 11.54 |
Edesa Biotech Inc (EDSA) 最新ニュース
EDSA stock touches 52-week low at $2.08 amid market challenges - Investing.com Canada
EDSA stock touches 52-week low at $2.08 amid market challenges By Investing.com - Investing.com South Africa
EDSA stock touches 52-week low at $2.27 amid market challenges - Investing.com Canada
500: Something went wrong - Investing.com
Edesa Leaps as CEO Boosts Holdings - Baystreet.ca
Edesa Biotech CEO invests $5 million in company By Investing.com - Investing.com India
Edesa Biotech’s Founder Makes Strategic Investment in the Company - GlobeNewswire
Edesa Biotech to Present at Global Conferences - Nasdaq
Edesa Biotech Announces Upcoming Conference Schedule - GlobeNewswire
Edesa Biotech Partners with Wainwright for Share Sales - TipRanks
Edesa Biotech (EDSA) Price Target Increased by 528.00% to 53.38 - MSN
Why Is Infectious Disease Player Edesa Biotech Stock Soaring Today? - MSN
Edesa Biotech (NASDAQ:EDSA) Shares Down 1.6% - Defense World
Pardeep Nijhawan Provides Update to Beneficial Ownership of Securities of Edesa Biotech, Inc. - GlobeNewswire Inc.
S&P Smallcap 600 (IQY) QuotePress Release - The Globe and Mail
1 Dividend Stock to Invest in the Domestic Steel Market Now - The Globe and Mail
Celsius Holdings Inc (CELH-Q) QuotePress Release - The Globe and Mail
Mackenzie Investments Announces Results of Special Meetings on Mutual Fund and ETF Mergers - Yahoo Canada Finance
ECB interest rate cut likely as Eurozone economy weaker than expected - Yahoo Finance UK
Veradigm Named as the Top Vendor for End-to-End Revenue Cycle Management Solutions - Yahoo Finance UK
Santander starts $1.7 billion share buyback programme - Yahoo Finance UK
FY2024 Earnings Estimate for Edesa Biotech, Inc. (NASDAQ:EDSA) Issued By HC Wainwright - Defense World
H.C. Wainwright bullish on Edesa Biotech stock amid BARDA study support - Investing.com
Edesa Biotech’s (EDSA) “Buy” Rating Reaffirmed at HC Wainwright - Defense World
EDSA: EB05 Selected for BARDA-Funded Study in ARDS… - Zacks Small Cap Research
Edesa Biotech Reports Fiscal 3rd Quarter 2024 Results - GlobeNewswire
Edesa Biotech (NASDAQ:EDSA) Stock Price Down 2% - Defense World
Edesa Biotech Inc expected to post a loss of 58 cents a shareEarnings Preview - XM
Ethiopian Airlines posts 14% jump in full-year revenue - Yahoo Finance UK
Alexis Shamess | Corporate/Commercial Lawyer in Toronto | People - Fasken
Myroslav Chwaluk | Mergers & Acquisitions Lawyer in Toronto | People - Fasken
A. Wojtek BaraniakPolish-speaking Corporate/Commercial lawyer in Toronto | People - Fasken
MoneySmart’s June Lucky Draw 2024 - Yahoo Finance
Ipsen and Foreseen Biotechnology announce exclusive global licensing agreement for antibody-drug conjugate with first-in-class potential - Yahoo Finance UK
Homebuilder Vistry boosts output target as cost inflation softens - Yahoo Finance UK
German environmental authorities approve Tesla site expansion - Yahoo Finance UK
Cipher Pharmaceuticals - The Pharma Letter
Edesa Biotech (NASDAQ:EDSA) Receives Buy Rating from HC Wainwright - Defense World
Allied gaming executive Choi buys shares worth $778k By Investing.com - Investing.com
Bioventus exec sells over $14k in company stock By Investing.com - Investing.com
Edesa's Paridiprubart Selected for U.S.-Funded Platform Trial in General ARDS - Contract Pharma
BARDA Selects Edesa Biotech's Drug for U.S. Funded Platform Trial in General ARDS - StockTitan
Edesa’s Paridiprubart Selected For U.S.-Funded Platform Trial In General ARDS - Contract Pharma
Comparing Assertio (NASDAQ:ASRT) and Edesa Biotech (NASDAQ:EDSA) - Defense World
Short Interest in Edesa Biotech, Inc. (NASDAQ:EDSA) Rises By 32.1% - Defense World
Perritt Capital Management Inc. Has $482000 Stake in Usio, Inc. (NASDAQ:USIO) - Defense World
Anixa Biosciences director buys shares worth over $1,000 By Investing.com - Investing.com
Stephens Inc. AR Has $1.30 Million Stock Holdings in DuPont de Nemours, Inc. (NYSE:DD) - Defense World
French jet engine maker Safran gets Italy's clearance to buy Microtecnica - Yahoo Finance UK
Edesa Biotech Shareholders Approve Board and Compensation PlansTipRanks.com - TipRanks
Edesa Biotech, Inc. Forecasted to Earn FY2024 Earnings of ($1.95) Per Share (NASDAQ:EDSA) - Defense World
Edesa Biotech Inc (EDSA) 財務データ
収益
当期純利益
現金流量
EPS
0.93%
3.55%
大文字化:
|
ボリューム (24 時間):